By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Life Science Nation (LSN) is pleased to announce the INNOPOLIS Jeonbuk as a Title Sponsor of RESI San Diego 2026.
As part of the Jeonbuk Advanced Bio Boost-Up Platform initiative, INNOPOLIS Jeonbuk will host the Jeonbuk Advanced Bio Boost-Up Innovation Showcase at RESI San Diego on Monday, June 22, 10:00am – 12:00pm, featuring innovative life science companies from South Korea. The showcase aims to highlight emerging Korean biotech and healthcare technologies while connecting participating companies with global investors, strategic partners, and commercialization opportunities.
The Jeonbuk Advanced Bio Boost-Up Platform initiative is supported by the Ministry of Science and ICT of Korea and the Korea Innovation Foundation (INNOPOLIS Foundation), with the goal of strengthening Jeonbuk’s position as a global bio innovation hub. Through this initiative, regional startups and emerging companies are being supported in their efforts to expand internationally and engage with the global life science ecosystem.
South Korea has rapidly emerged as one of Asia’s leading biotechnology and healthcare markets, supported by strong scientific talent, advanced manufacturing capabilities, and increasing government investment in innovation. Within this landscape, Jeonbuk is actively developing its bio industry through strategic support for therapeutics, medical devices, digital health, diagnostics, regenerative medicine, and advanced biomanufacturing.
Participating companies include:
WittGen Biotechnologies – developer of a GenAI-based single-cell multi-omics simulation platform focused on oncology, immunology, and rare diseases.
Cellebrain – advancing MSC-based gene delivery technologies for oncology, fibrosis, and rare disease applications.
Youth Bio Global – developing allogeneic ECFC-based regenerative cell therapy platforms targeting vascular regeneration and ischemic diseases.
Erudio Bio Korea – developer of semiconductor-based multiplex diagnostic and AI molecular analysis technologies for preventive screening and oncology applications.
BASGENBIO Co., Ltd. – an AI-driven drug discovery company focused on target discovery and preclinical decision-support technologies.
VIEL-T Co., Ltd. – developing programmable RNA therapeutics platforms for next-generation precision medicine applications.
In connection with the initiative, INNOPOLIS Jeonbuk recently hosted the Global Investment Attraction Strategy & IR Capability Enhancement Seminar on May 21, 2026, at the Jeonbuk Techno Business Center in South Korea. The seminar brought together regional biotech companies, ecosystem stakeholders, and industry experts to discuss global fundraising strategies, investor engagement, and international commercialization opportunities for Korean life science companies.
As part of the program, Life Science Nation (LSN) shared insights on:
- Global fundraising and investor outreach strategies
- Building effective IR and partnering pipelines
- Preparing Korean startups for international investors and markets
- Opportunities through RESI and the global LSN ecosystem
The event also included the signing of a Memorandum of Understanding (MOU) between LSN and BSR Korea to strengthen collaboration in supporting Korean biotech and healthcare companies seeking global expansion and cross-border partnership opportunities.
Through the showcase at RESI San Diego 2026, INNOPOLIS Jeonbuk seeks to strengthen cross-border collaboration and provide Korean startups with greater access to global capital and partnering opportunities.
The program will feature:
- An introduction to the Jeonbuk bio ecosystem and the Jeonbuk Advanced Bio Boost-Up Platform initiative
- Startup pitches from participating Korean life science companies
- Investor and industry expert feedback sessions
- Networking opportunities with global investors and strategic partners
RESI San Diego 2026 will take place on Monday, June 22, at the JULEP Venue in San Diego. Join us for a full day of one-on-one partnering meetings, engaging programming, and the opportunity to build meaningful connections within the global life sciences ecosystem.
About INNOPOLIS Jeonbuk
The INNOPOLIS Jeonbuk is part of Korea’s national innovation cluster network operated by the Korea Innovation Foundation under the Ministry of Science and ICT. Based in Jeonbuk Special Self-Governing Province, the cluster supports the commercialization and global expansion of innovative technologies and startups across the life sciences sector.
Through the Jeonbuk Advanced Bio Boost-Up Platform initiative, the cluster is focused on strengthening regional bio innovation capabilities and supporting Korean life science companies in accessing global investors, strategic partners, and international markets.
As a Title Sponsor of RESI San Diego 2026, the INNOPOLIS Jeonbuk aims to expand global collaboration opportunities for Korean startups and further connect the Korean bio ecosystem with the international life science community.
| Register for RESI San Diego |
Next Phase Newsletter 
Leave a comment